From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….
Genome Insight Launches in the U.S. with Innovative Whole Genome Sequencing Approach that Offers Unprecedented, Actionable Insights in Cancer Care
Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine